{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:26Z","timestamp":1761630446303,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":5736,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1111\/j.1600-6143.2006.01691.x","type":"journal-article","created":{"date-parts":[[2007,3,26]],"date-time":"2007-03-26T09:32:48Z","timestamp":1174901568000},"page":"847-856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft Survival"],"prefix":"10.1016","volume":"7","author":[{"given":"L.L.","family":"Langan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.L.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Irish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Luxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.T.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2006.01691.x_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ki.1996.460","article-title":"The humoral immune response towards HLA class II determinants in renal transplantation","volume":"50","author":"Feucht","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007890-200002150-00001","article-title":"Anti-HLA antibodies after solid organ transplantation","volume":"69","author":"McKenna","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1523-1755.2001.00495.x","article-title":"Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts","volume":"59","author":"Lederer","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","article-title":"Humoral theory of transplantation: Further evidence","volume":"17","author":"Terasaki","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib5","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/00007890-199706150-00014","article-title":"Postoperative production of anti-donor antibody and chronic rejection in renal transplantation","volume":"63","author":"Abe","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0041-1345(00)02099-6","article-title":"An association between postransplant antibody production and renal transplant rejection","volume":"33","author":"Worthington","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0041-1345(00)02101-1","article-title":"Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome","volume":"33","author":"Piazza","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.TP.0000055833.65192.3B","article-title":"Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome","volume":"75","author":"Worthington","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.TP.0000078895.24606.45","article-title":"Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy","volume":"76","author":"Martin","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1432-2277.2005.00085.x","article-title":"Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation","volume":"18","author":"Cardarelli","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1399-0039.2005.00382.x","article-title":"Anti-HLA class II antibodies in kidney retransplant patients","volume":"65","author":"Arnold","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib12","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-200210270-00025","article-title":"All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies","volume":"74","author":"Lee","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: A prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.tp.0000174338.97313.5a","article-title":"Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial","volume":"80","author":"Terasaki","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg\u2013Reed cells of Hodgkin's disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007890-199805150-00016","article-title":"CD30 expression identifies a functional alloreactive human T-lymphocyte subset","volume":"65","author":"Martinez","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00062752-200307000-00003","article-title":"Expression and a role of CD30 in regulation of T-cell activity","volume":"10","author":"Tarkowski","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0966-3274(03)00014-5","article-title":"CD30 antigen: Not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1\/TH2 response","volume":"12","author":"Pelligrini","year":"2003","journal-title":"Transpl Immunol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00007890-200201150-00002","article-title":"Soluble CD30 as a predictor of kidney graft outcome","volume":"73","author":"Pelzl","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/01.ASN.0000014256.75920.5B","article-title":"Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30","volume":"13","author":"Susal","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.TP.0000044702.18327.66","article-title":"Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection","volume":"75","author":"Pelzl","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.TP.0000152660.56055.53","article-title":"Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations","volume":"79","author":"Cinti","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trim.2005.03.014","article-title":"Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection","volume":"14","author":"Slavcev","year":"2005","journal-title":"Transpl Immunol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1600-6143.2005.00966.x","article-title":"High pre-transplant soluble CD30 levels are predictive of the grade of rejection","volume":"5","author":"Rajakariar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib27","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.transproceed.2005.02.088","article-title":"sCD30 and neopterin as risk factors of chronic renal transplant rejection: Impact of cyclosporine A, tacrolimus, and mycophenolate mofetil","volume":"37","author":"Weimer","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1600-6143.2006.01407.x","article-title":"Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: Impact of different immunosuppressive regimens","volume":"6","author":"Weimer","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1681\/ASN.V133779","article-title":"Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology and pathologic classification","volume":"13","author":"Mauiyyedi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1399-0012.2000.140116.x","article-title":"Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation","volume":"14","author":"Muller-Steinhardt","year":"2000","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib31","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.transproceed.2004.08.091","article-title":"Effect of posttransplant anti-HLA antibody on outcome of renal transplantation","volume":"36","author":"Vareesangthip","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.humimm.2005.07.005","article-title":"HLA antibody identification with single antigen beads compared to conventional methods","volume":"66","author":"El-Awar","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfh527","article-title":"Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA\u2122, ELISA and CDC vs Luminex screening","volume":"20","author":"Muro","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib34","doi-asserted-by":"crossref","first-page":"s108","DOI":"10.1016\/j.humimm.2003.08.201","article-title":"Accurate, rapid characterization of HLA specific antibody using Luminex technology","volume":"64","author":"Pretl","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1600-6143.2006.01691.x_bib35","article-title":"Luminex","author":"Herczyk","year":"2003","journal-title":"Vendor Forum ASHI Quarterly"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2006.01691.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352214654X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352214654X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2006.01691.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:41:44Z","timestamp":1761626504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352214654X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S160061352214654X"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01691.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft Survival","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01691.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}